Dr. Reddys Laboratories Ltd.

BSE: 500124 | NSE: DRREDDY
Large Cap | Pharmaceuticals & Drugs
1175.55
-10.90 (-0.92%)
< Home < Back

Dr Reddy's Laboratories gets EIR for manufacturing facility in Andhra Pradesh

Date: 26-08-2022

Dr. Reddy's Laboratories has received Establishment Inspection Report (EIR) for its formulations manufacturing facility (FTO 11) in Srikakulam, Andhra Pradesh. The agency has concluded that the inspection is ‘closed’.

Earlier, in July, United States Food & Drug Administration (USFDA) had conducted inspection at the company’s FTO 11 in Srikakulam.

Dr. Reddy's Laboratories is a multinational pharmaceutical company based in Hyderabad, Telangana in India. It manufactures and markets a wide range of pharmaceuticals in India and overseas.